RENEW · Hormone and cellular care
CJC/Ipamorelin
Understand the combination before the decision.
This peptide combination involves pathways associated with growth hormone release. The exact ingredients and available evidence deserve careful review.
Prescription required. Provider evaluation determines eligibility.
CJC-related peptides and ipamorelin are different substances. The CJC form, including whether it contains a drug affinity complex, must be identified.
The components interact with different growth-hormone-related signaling pathways. Combining them does not establish better outcomes or a proven adult wellness benefit.
Directions require a verified formulation and route. Do not use a dosing schedule written for a different CJC product or concentration.
Clinical review should include endocrine history, current medicines, relevant laboratory findings and alternatives with better established evidence.
Two distinct components.
Evidence for the blend.
CJC-related peptides and ipamorelin are different substances. The CJC form, including whether it contains a drug affinity complex, must be identified.
-
Two distinct components
The precise CJC identity must be specified.
-
Mechanism is not benefit
Signaling activity does not prove wellness outcomes.
-
Evidence for the blend
Ask about the combination, not just its ingredients.
Care starts with
understanding you.
A treatment decision should take your health history, current medications and goals into account. Your evaluation is the place to discuss questions, potential risks and whether another approach may be more appropriate.
-
Your health in context
Share your medical history, current medications and treatment goals.
-
A considered decision
Discuss the evidence, potential risks and available alternatives.
-
Clear next steps
If treatment is prescribed, follow the instructions for your exact medication and ask how follow-up will work.
Explore your options
with context.
Different treatments have different uses, risks and levels of evidence. Explore this care category, then discuss the options that may fit your clinical needs.
Explore hormone and cellular care-
Glutathione
Glutathione is present in human cells.
Glutathione is a molecule involved in cellular redox balance. Its natural presence does not mean that taking additional glutathione will produce a particular benefit.
Learn more -
SS-31 Injection
SS-31 refers to elamipretide.
Elamipretide is a peptide that targets mitochondrial cardiolipin. FDA-approved Forzinity has a specific indication for improving muscle strength in patients with Barth syndrome weighing at least 30 kg.
Learn more -
Kisspeptin Injection
Kisspeptin acts within the reproductive hormone axis.
Kisspeptin refers to a family of peptides involved in the reproductive hormone axis. The exact peptide form in a formulation matters.
Learn more
A plan begins with
an evaluation.
Completing an assessment does not guarantee a prescription.
-
Share your history
Provide information about your health, medications and goals.
-
Review the options
A licensed provider evaluates whether treatment is clinically appropriate. Further information, testing or another type of care may be needed.
-
Understand your prescription
If prescribed, review the medication, administration directions, risks and follow-up plan before starting.
-
Revisit the plan
Discuss your response and any concerns with your prescriber. Do not change a dose or combine treatments on your own.
Know the important
information.
Every medication has potential risks. Review the complete safety information for the exact product and tell your provider about your medical conditions, allergies, pregnancy or pregnancy plans, and all medicines and supplements you take.
Compounded medications are not FDA-approved. FDA does not evaluate these preparations for safety, effectiveness or quality before marketing.
Human safety data may be incomplete. Ingredient identity, purity, formulation and administration route matter; an ingredient’s research history does not establish the safety of a blend.
Seek emergency care for trouble breathing or swelling of the face, lips or throat. Contact a clinician promptly for severe or concerning symptoms. Do not rely on routine online messaging for an emergency.
Frequently asked questions
Those benefits are not established for this proposed preparation.
No. The ingredients and signaling activity differ.
Different CJC-related products can have different properties. Your provider needs the exact substance.
A licensed provider considers your health history, current medications, clinical needs and the evidence for the specific treatment. Further testing or a different type of care may be recommended.
No. A prescription is provided only when the evaluating provider determines that treatment is medically appropriate and available.
Follow your prescriber and pharmacy's instructions for the exact product. Ask before changing a dose, switching formulations or combining treatments.
Your next step starts with your
health.
Share your history and goals so a licensed provider can evaluate which care options may be appropriate for you.
Prescription required. Treatment is not appropriate for everyone. Assessment does not guarantee a prescription.